UB Paderborn / Katalog / Suche / in CDI

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

Transplant infectious disease, 2013-06, Vol.15 (3), p.259-267

2013

Volltextzugriff (PDF)

Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (7), p.751-758

2004

Volltextzugriff (PDF)

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Blood, 2009-08, Vol.114 (7), p.1437-1444

2009

Volltextzugriff (PDF)

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery

Experimental hematology, 2006-03, Vol.34 (3), p.389-396

2006

Volltextzugriff (PDF)

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome

American journal of hematology, 2013-07, Vol.88 (7), p.581-588

2013

Volltextzugriff (PDF)

Dendritic cell recovery after autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2002-09, Vol.30 (5), p.261-266

2002

Volltextzugriff (PDF)

Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy

Bone marrow transplantation (Basingstoke), 2003-05, Vol.31 (9), p.789-794

2003

Volltextzugriff (PDF)

Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome

Haematologica (Roma), 2006-02, Vol.91 (2), p.258-261

2006

Volltextzugriff (PDF)

Reduced Intensity HLA-Id Sibling Stem Cell Transplantation: Role of KIR Polymorphism

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S342-S342

2011

Volltextzugriff (PDF)

A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome

Haematologica (Roma), 2000-09, Vol.85 (9), p.943

2000

Volltextzugriff (PDF)

Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation

Haematologica (Roma), 2006-09, Vol.91 (9), p.1268-1272

2006

Volltextzugriff (PDF)

Safety and pharmacokinetics of intravenous versus oral busulfan used in pretransplantation myeloablative conditioning therapy.(Early side effects/Late effects and quality life)(Author abstract)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S177

2009

Volltextzugriff (PDF)

Prognostic factors and outcome of E pstein– B arr virus DNA emia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

Transplant infectious disease, 2013-06, Vol.15 (3), p.259-267

2013

Volltextzugriff (PDF)

Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients : effect of a brief course of G-CSF on harvest and recovery

Bone marrow transplantation (Basingstoke), 1999-10, Vol.24 (7), p.757-761

1999

Volltextzugriff (PDF)

Myasthenia gravis after allogeneic bone marrow transplantation: a case report

Bone marrow transplantation (Basingstoke), 1995-04, Vol.15 (4), p.649

1995

Volltextzugriff (PDF)

Graft-versus-host disease and fungal infections are the main outcome predictors after allogeneic stem cell transplantation using reduced-intensity conditioning regimens.(Infectious complications)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S250

2009

Volltextzugriff (PDF)

Successful cord blood stem cell transplantation for advanced acute myeloid leukaemia in an adult patient with history of orthotopic liver transplantation.(Stem cell source)(Author abstract)(Case study)

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (S1), p.S377

2009

Volltextzugriff (PDF)

Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission : a retrospective analysis of the outcome of 52 patients according to the age-adjusted international prognostic index

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (3), p.263-271

1998

Volltextzugriff (PDF)

D-Verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin

Anti-cancer drugs, 1993-04, Vol.4 (2), p.173-180

1993

Volltextzugriff (PDF)

Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests

Haematologica (Roma), 1995-09, Vol.80 (5), p.443

1995

Volltextzugriff (PDF)

Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients

Blood, 1997-07, Vol.90 (1), p.36-42

1997

Volltextzugriff (PDF)

Risk Factors and Outcome of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2016

2016

Volltextzugriff (PDF)

Primary Systemic CD30 (Ki-1)-Positive Anaplastic Large Cell Lymphoma of the Adult: Sequential Intensive Treatment With the F-MACHOP Regimen (±Radiotherapy) and Autologous Bone Marrow Transplantation

Blood, 1996-02, Vol.87 (4), p.1243-1248

1996

Volltextzugriff (PDF)

High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome

Haematologica (Roma), 2000-03, Vol.85 (3), p.269

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome

Dendritic cell recovery after autologous stem cell transplantation

Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy

Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome

Reduced Intensity HLA-Id Sibling Stem Cell Transplantation: Role of KIR Polymorphism

A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of autologous stem cell transplantation in first remission on outcome

Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation

Safety and pharmacokinetics of intravenous versus oral busulfan used in pretransplantation myeloablative conditioning therapy.(Early side effects/Late effects and quality life)(Author abstract)

Prognostic factors and outcome of E pstein– B arr virus DNA emia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients : effect of a brief course of G-CSF on harvest and recovery

Myasthenia gravis after allogeneic bone marrow transplantation: a case report

Graft-versus-host disease and fungal infections are the main outcome predictors after allogeneic stem cell transplantation using reduced-intensity conditioning regimens.(Infectious complications)

Successful cord blood stem cell transplantation for advanced acute myeloid leukaemia in an adult patient with history of orthotopic liver transplantation.(Stem cell source)(Author abstract)(Case study)

Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission : a retrospective analysis of the outcome of 52 patients according to the age-adjusted international prognostic index

D-Verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin

Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests

Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients

Risk Factors and Outcome of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation

Primary Systemic CD30 (Ki-1)-Positive Anaplastic Large Cell Lymphoma of the Adult: Sequential Intensive Treatment With the F-MACHOP Regimen (±Radiotherapy) and Autologous Bone Marrow Transplantation

High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome

Suchergebnisse filtern